Advanced search
Publication Cover
Current Medical Research and Opinion Volume 24, 2008 - Issue 5
Submit an article Journal homepage
94
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Costs and persistence of carbonic anhydrase inhibitor versus alpha‑2 agonists, associated with beta-blockers, in glaucoma and ocular hypertension: an analysis of the UK‑GPRD database*

A. LafumaCemka Bourg-la-ReineFrance
&
G. BerdeauxAlcon France Rueil-MalmaisonFrance
Pages 1519-1527 | Accepted 06 Mar 2008, Published online: 14 Apr 2008

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Gregory Reardon, Sameer Kotak & Gail F Schwartz. (2011) Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review. Patient Preference and Adherence 5, pages 441-463.
Read now

Articles from other publishers (6)

Daniel B. Horton, Harshvinder Bhullar, Lucy Carty, Francesca Cunningham, Alexis Ogdie, Janet Sultana & Gianluca Trifirò. 2019. Pharmacoepidemiology. Pharmacoepidemiology 241 289 .
Jennifer Burr & Luke Vale. 2015. Glaucoma. Glaucoma 509 513 .
Jens Olsen, Gilles Berdeaux & Jesper Skov. (2011) Glaucoma costs in Denmark in treatment naive patients. Acta Ophthalmologica 91:1, pages 25-31.
Crossref
Alexis Ogdie, Sinéad M. Langan, John Parkinson, Hassy Dattani, Karel Kostev & Joel M. Gelfand. 2012. Pharmacoepidemiology. Pharmacoepidemiology 224 243 .
Stella Arthur & Louis B. Cantor. (2011) Update on the role of alpha-agonists in glaucoma management. Experimental Eye Research 93:3, pages 271-283.
Crossref
Vicky H. Lu, Ivan Goldberg & Christine Y. Lu. (2010) Use of Glaucoma Medications: State of the Science and Directions for Observational Research. American Journal of Ophthalmology 150:4, pages 569-574.e9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.